Abbreviated MRI is superior to whole-breast ultrasound for detection of cancer in dense breasts
1. Abbreviated MRI detected three times as many invasive cancers compared with ABUS. 2. Contrast-enhanced mammography detected a greater number...
Chronic Disease
Reports of high-impact chronic disease studies by medical professionals
Volumetric diet and time-restricted eating demonstrate similar outcomes for weight reduction
1. In this randomized controlled trial comparing the volumetrics diet (VD) and time-restricted eating (TRE), both interventions led to significant...
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
1. Median overall survival was 13.6 months in the tarlatamab group and 8.3 months in the chemotherapy group, with HR...
Reductions in pain catastrophizing are associated with improvements in emotional functioning
1. Reductions in pain catastrophizing are more closely associated with improvements in emotional functioning than with pain intensity Evidence Rating...
Artificial intelligence may assist in early detection of decreased ejection fraction on echocardiograms
1. AI-assisted electrocardiogram (ECG) improves early detection of low ejection fraction in hospitalized patients by enhancing diagnostic precision without increasing...
Frailty scores alone may be poor predictors of intensive care admission or hospital stay duration
1. Frailty scores alone (mFI-5, CCI) are poor predictors of intensive care unit (ICU) admission or prolonged hospital stay in...
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
1. Event-free survival at 24 months was 67.4% in the durvalumab group and 58.5% in the placebo group, with HR...
Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis
1. Prediagnostic use of anxiolytics, hypnotics, sedatives and antidepressants were associated with a higher risk of amyotrophic lateral sclerosis (ALS). ...
Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer
1. Median overall survival was 3.1 months greater in the nivolumab plus ipilimumab group. 2. Grade 3-4 treatment-related adverse events...
Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis
1. The use of dapagliflozin in patients with metabolic dysfunction-associated steatohepatitis (MASH) resulted in a higher proportion of improvement of...